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Abstract

Work conducted in the Millard Biochemistry Research Laboratory examines the dual
nature of molecules as carcinogens and anti-tumor agents through the molecular
mechanisms of duplex DNA damage by bifunctional alkylating agents. Diepoxybutane (DEB)
and epichlorohydrin (ECH) are polar molecules that form covalent DNA interstrand lesions
by cross-linking the N7 position of deoxyguanosine residues. A recent experiment indicated
that ECH preferentially targets nuclear DNA over mitochondrial DNA, whereas DEB shows
similar rates oflesion foonation for both loci. It was concluded that preferential targeting of
nuclear DNA results from relatively poor uptake of ECH across the mitochondrial membrane.
The objective of my honors research was to determine if the cytotoxicities of DEB and ECH
vary according to the presence of the nuclear envelope in 6C2 chicken erythro-progenitor
cells. The cytotoxicity of DEB and ECH was compared ben-.een cells randomly distributed
throughout the cell cycle (Go/G, and S » G2/M) and cells enriched in G2/M stages. Results
indicated that ECH is more cytotoxic than DEB in both unsynchronized control 6C2 cells and
synchronized 6C2 cells enriched in G2 /M stages of the cell cycle. Treatment with either
bifunctional alkylating agent induced greater cytotoxicity in 6C2 cells enriched in Gd'Yl
stages than in unsynchronized control 6C2 cells, suggesting that the presence of the nuclear
envelope-or any plasma membrane-may inhibit the reactivity of DEB and ECH.

Introduction

It has been almost a decade since cancer surpassed heart disease as the leading cause
of death for Americans 85 years of age and younger'. Though the annual mortality rates of
both diseases have exhibited a downward trend, it is apparent that the treatment of cancer
continues to challenge both the medical and scientific communities. In

2008,

more than

565,650 cancer-related deaths are predicted to occur in the United States alone, a country
where 1 in 2 men and 1 in 3 women will battle a variety of cancers in their lifetimes 2 • The
probability of developing some form of malignancy during one's lifetime is influenced by
various factors, such as exposure to carcinogens in the environment and our lifestyle choices.
Likewise, an individual's genetic composition determines his or her predisposition toward
developing cancer.
Studies conducted in the Millard Biochemistry Research Laboratory aim to elucidate
the molecular mechanisms of duplex DNA damage by bifunctional alkylating agents to gain
insight into the dual nature of molecules that can act as carcinogens or anti-tumor agents.
Also knov·,'ll as cross-linkers, these molecules have been used as chemotherapeutic agents
since the chance discovery of the lymphotoxic action of nitrogen mustards during World War
13.
The cytotoxic mechanisms of the bifunctional alk}rlators diepoxybutane (DEB) and
epichlorohydrin (ECH) are of particular interest (Figure 1). These small, relatively polar
molecules contain two reactive moieties that form covalent D~A interstrand lesions by
preferentially cross-linking the N7 position of deoxyguanosine residues on opposite
strands4 .5,6. Interstrand cross-links interfere with the normal cellular process of replication
fork progression during DNA synthesis and may potentially disrupt transcription if not
repaired.

~ucleotide-excision repair,

homologous recombination, al1.-yltransferases, and

2

o

\7
o

/\
Epichlorohydrin

Diepoxybutane

Figure 1. Chemical structures of diepoxybutane and epichlorohydrin. The structure of DEB
contains two epoxide rings. ECH is characterized by two functionalities: an expoxide ring and
a terminal chloride.

the Fanconi Anemia repair pathway are known to correct interstrand lesions resulting from
reaction with bifunctional alkylating agents 7 ,
DEB is a metabolite of 1,3-butadiene (BD), a chemical used in the synthetic elastomer
industry. BD is most abundantly used during the polymerization of styrene-butadiene
rubbertl·S,<). In addition to industrial chemistry, BD is an environmental air pollutant
produced by internal combustion engines and cigarette smokes, Prior to the 1980s,
occupational exposure to BD was relatively unregulated with a Permissible Exposure Limit
(PEL) of 1,000 ppm set by OSHA. However, studies perfonned in the 1980s on BD exposure
in rat models indicated that the agent metabolizes to active compounds with definitive
carcinogenic properties. This prompted OSHA to lower its ceiling PEL from

1,000

ppm to 10

ppm'O,lI.
Genotoxic effects of DEB include DNA interstrand cross-links in mouse hepatocytes,
sister chromatid exchange (SCE) or recombination, and chromosomal aberrations in cultured
cell models. Employees exposed to BD and its physiological metabolite DEB exhibit
statistically significant increases in the development of hematopoietic cancers 12,13.14. The
World Health Organization's International Agency for Research on Cancer (lARC) currently
classifies DEB as a probable human carcinogen. Animal models provide sufficient evidence
for carcinogenicity, but data linking human cancer cases directly to DEB exposure .....i thout
other confounding variables are limited15.
Additionally, DEB is commonly used to test for the Fanconi Anemia (FA) cellular
phenotype. Patients with hereditary FA have mutations in proteins of the FA D~A repair
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pathway, which promotes the repair of stalled replication forks during DNA synthesis.
Impairment of FA repair mechanisms leads to cellular hypersensitivity to DKA interstrand
cross-links, resulting in prolongation and ultimate arrest within the G:l. stage of the cell
cycle7.16.17.18.
DEB, a four-carbon molecule containing two symmetric epoxide rings, reacts
predominantly with the N7 position of deoxyguanine residues during the formation of
interstrand cross-links4 .s. The nitrogen at position 7 of the guanine ring is the most
nucleophilic atom in DNA. In addition to high electrophilicity, the location of N7 makes it
sterically available for reaction with larger molecules (Figure 2). N7 first opens one epoxide
ring through nucleophilic attack at the secondary, less-substituted carbon. The process is
repeated by a guanine N7 residue on the opposing strand of duplex DNA, which opens the
second epoxide ring and fonns the covalent linkage. Negatively charged oxygens resulting
from the loss of the two epoxide rings are protonated under physiological conditions (Figure
2)6,9.

DEB preferentially targets 5' GNC sequences, where N is representative of either

guanine or cytosine residues 4 •19 .

Figure 2. Chemical structures of covalent DNA interstrand cross-links. LEFT: DEB fonns a cross-link
between deoxyguanosine residues on opposing strands of DNA6.9. RIGHT: ECH cross-links two
deoxyguanosine residues of duplex DNA21. The positive charge on the N7 nitrogen makes these cross-links very
unstable; it has been proposed that such instability leads to the breakdown of the DNA double helLx.

4

Epic.hlorobydrin is commonly used as an intermediate in the synthesis of products
such as epoxy resins, synthetic glycerine, and surfactants in the polymer industl}'20. Research
performed with yeast and mice systems by Van Duuren and Goldschmidt suggests that
epoxide-containing compounds are largely mutagenic and likely have carcinogenic properties
arising from their ability to modify DNA6.21.
Approximately 80,000 US employees were occupationally exposed to ECH bet",;een
1981-1983 20 • OSHA designates the PEL for ECH at 2 ppm TWA (time-weighed average
reflecting an 8-hour work sbift)lO,lI. Human exposure to 20 ppm ECH leads to irritation of
mucosal membranes, nausea, dyspnea, and englargement of the liver. Brief exposure to ECH
concentrations about 100 ppm results in lung edema and kidney lesions lO,ll. Experiments that
examine incidence of exposure to ECH and cancer rates among employees suggest a
significantly higher risk of developing lung cancer, although the link between ECH and
malignancy is controversial 20 ,22. Currently, the IARC classifies both ECH and DEB as
probable human carcinogens 1s .
ECH has the potential for nucleophilic attack by the N7 deoxyguanine residue at both
the less-substituted epoxide ring carbon and the carbon-chlorine bond (Figure 2). ECH
targets both 5' GNC and 5' GC sequences, where N is representative of either guanine or
cytosine residues~3. During the formation of a mono-adduct through reaction with ECH, 1\7
acts as a nucleophile and opens the epoxide ring by attack at the secondal}' carbon. The
negatively charged oxygen atom performs an S~2 reaction, releasing chloride and forming a
new epoxide ring. The N7 of a guanine residue located on the complemental}' strand
nucleophilically attacks the new ECH epoxide ring at the less substituted carbon, creating a
covalent interstrand cross-link. Under aqueous conditions, the negatively charged oxygen is
protonated22,2~~.

We are interested in the relationship between DEB and ECH toxicity and the relative
availability of DNA throughout the cell cycle. Accumulation of DNA damage is a hallmark of
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Cells in G1-"Gap l"-undergo growth andperfonn damage control to monitor the
results of the most recent cell division. Given enough stimulation via hormonal signaling for
regulatory complexes, cells "ill pass the restriction point and enter into S stage:

D~A

synthesis. Progression past the restriction point commits the cell to division. G2, also kno'\o\'ll

as "Gap

2,"

is a time of cellular growth and damage controlleacling up to entry into M

stag&4·:!I).
Mitosis consists offour phases: prophase, metaphase, anaphase, and telophase. The
process of nuclear division begins with prophase, during which DNA condenses into
chromosomes, the nuclear envelope disintegrates, and mitotic spindle fibers form and attach
to chromosomes at kinetochores. Each of the above processes is facilitated by the
maturation-promoting factor (MPF), the M stage Cdla-Cyclin Bl complex. Notably, MPF
phosphorylates nuclear lamins A, B, and C at serine residues, causing a conformational
change to occur in scaffolding proteins and stimulating the depolymerization of the filaments
that compose the lamin structure. Lamin B remains bound to nuclear membrane \"esicles \1a
a hydrophobic isoprenyl group at the e-tenninus24.27,28.
During metaphase, chromosomes align along the equatorial axis of the cell. Sister
chromatids separate and move to each of the two poles through microtubule
deplo)omerization at the kinetochore. The poles of the cell also increase the distance between
one another in preparation for cytokinesis through molecular motor movement,
polymerization of polar microtubules, and depolymerization of astral microtubles. Telophase
marks the final step in nuclear division, during which the nuclear envelope reassembles, DNA
decondenses, and mitotic spindles depolymerize. These steps are facilitated by the
polyubiquination of Cyelin Bl and consequent degradation of MPF. Phosphorylation events
perfonned by MPF during prophase are reversed via the dephosphorylation of cellular
proteins by phosphatases24 ,2 7 •
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Cytokinesis, or cellular division, is the final step of the M stage. Breakdo....n of MPF,
which phosphorylates an inhibitory residue on myosin light chains within the cleavage
furrow, allows for the activation of myosin. Contractile interactions between myosin and
action result in complete cellular cleavage24 •
As illustrated by the various signaling pathways of the cell cycle, healthy cells are fully

integrated with the extracellular environment and other neighboring cells, only entering the
cell cycle when the summation of stimulatory signals is greater than that of inhibitory signals
for cell di\ision. As the degree of genomic instability increases, progeny of afflicted cells fail
to respond to extracellular communication \ia growth factors and other hormone signals.
These cells, having fallen out of synch ....ith their environment, experience the disruption of
signaling pathways that causes cells to display erratic behavior, namely uncontrolled cell
division 29•
Under most conditions unfavorable genetic mutation results in cytotoxic effects and
cell death; however, mutations affecting the activity of proto-oncogenes and tumor
suppressor genes that are part of various DNA repair pathways may result in the deregulation
of the cell cycle and give rise to cancer. One commonly affected pathway includes P53, a
tumor suppressor gene, which mediates an important cell cycle chec1..-point in the presence of
DNA damage27.3 o . Arrest of the cell cycle allows for the repair of damage sustained during a
previous phase. The absence or complete avoidance of cell cycle checkpoints compromises
the genetic fitness of the cell; hence, signal molecules invoh'ed in checkpoints and cell cycle
arrest are vital to normal function and proliferation 27.31 . As previously stated, cells displaying
the FA phenotype arrest in G2 when exposed to DEB7. 16,17.•8. Human diploid fibroblasts
treated \\ith ECH at doses above 0.5 mM/hour arrest in G. 6-18 hours after initial exposure32 .
Additionally, mutations to kinases and phosphatases involved in signaling pathways
may result in the overexpression of regulatory elements and have similar deleterious effects
on the normal progression of the cell cycle. Interestingly, lymphomas, liver and lung tumors
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resulting from DEB exposure in murine models are characterized by activated K-Ras
oncogenes and lymphoma-specific P53 mutations 15 .
The most recent study completed by the Millard Biochemistry Research Team
examined the relationship between chromatin structure and DNA damage by DEB, ECH, and.
the related epihalohydrin, epibromohydrin (EBH), at three loci: expressed nuclear DNA,
unexpressed nuclear DNA, and "naked" mitochondrial DNA 6C2 ,chicken erythro-progenitor
cells were treated independently with

250

mM of the three bifunctional alkylating agents for

various incubation times. Quanrita6ve polymerase chain reaction (QPCR) was performed
using a limited. amount of template DNA isolated from the treated cells. QPCR compares the
amount of amplification of control, untreated DNA to that from cells treated with the agent in
question 33 • QPCR data were analyzed via the Poisson expression; plots were constructed for
lesion frequency versus incubation time, showing a linear trend-line with a slope equal to the
lesion frequency per unit time34.
Data indicated that nuclear DNA damage occurs at comparable levels for DEB, ECH,
and EBH treated cells, regardless of chromatin structure ("open" expressed versus
"condensed" unexpressed). The study also found that ECH and EBH preferentially target
nuclear DNA over mitochondrial DNA., whereas DEB shows similar rates oflesion formation
for both loci. A three to four-fold increase in lesion formation occurred for both nuclear
heterochromatin and euchromatin treated with ECH or EBH versus treated mitochondrial
DNA. The conclusion was that preferential targeting of nuclear DNA results from relatively
poor uptake of ECH and EBH across the mitochondrial membrane35. In general, compounds
experience poor mitochondrial uptake as a result of small, polar chemical composition; the
high lipid-to-DNA ratio of mitochondria favor the uptake oflarger, lipophilic molecuIes36 •
In this study, we sought to investigate the cytotoxicity of DEB and ECH in relation to
the cell cycle. Specifically, the m.ain obj'ective of the study was to determine whether the
presence of the nuclear envelope significantly influences the cytotoxicity of DEB and ECH.

9

6C2 chicken eI)thro-progenitor cells served as our model cell line; exposure to many

bifunctional alkylating agents corresponds to an increase in the risk of developing various
hematopoeitic cancers, making organelle-containing eI)rthro-progenitor cells an optimal
system for our topic of srudyI2,13,14.
The cytotoxicity of DEB and ECH was compared between populations of cells
randomly distributed throughout the cell cycle (GO/G 1and S » G2/M) and those populations
of cells enriched in G2/M stages. LD50 values were determined for 30 minute, 60 minute,

120

minute, and 180 minute treatment periods for each of the four categories: DEB
unsynchronized control cells, DEB cells enriched in G2/M stages, ECH unsyncbronized
control cells, and ECH cells enriched in G2 /M stages. It is our hope that investigating the role
of the cell cycle in relation to DEB and ECH will provide insight into the carcinogenic nature
of these bifunctional al1..·ylators.

10

Materials and Methods

Cell Culture. 6C2 chicken (Gallus gallus) erythro-progenitor cells were cultured in
growth media composed ofMEM Richter's modification v.;th L-glutamine, 10% heat~
inactivated fetal bovine serum,
~1M ~-mercaptoethanol,88

2%

heat-inactivated chicken serum, 1 m.M: HEPES buffer, 50

units/mL penicillin, 88 flg/mL streptomycin, and 0.2 I-lg/mL

amphotericin B. Cells were grown in T25 culture flasks maintained at 37°C and 5% C02. 85
90% confluent 6C2 cell suspensions were passaged by 1:5 (1 mL cell suspension and 4 mL

culture media),

1:10 (1

roL cell suspension and 9 roL culture media), or 1:20 (0.5 mL cell

suspension and 9.5 mL culture media) dilutions to maintain the cell line. Informal
measurements by Newman (unpublished data) suggest a population doubling time of 6-8
hours and approximately 2 days of growth for 6C2 chicken erythro-progenitor cells to reach
85-90% confluence.
Additional 6C2 cells from the first three passages were frozen and stored in liquid
nitrogen for preservation of the cell line. The contents of one T -25 culture flask were
transferred to a 15 mL conical Falcon tube and centrifuged at 300 x g for 5 minutes. The
supernatant was removed and discarded. The pellet was suspended in cold 6C2 cell culture
media supplemented v.ith 10% DMSO to achieve a concentration of 1 x 10 6 to 1 X 10 7
cells/mL. 1 mL aliquots of the cell suspension were transferred to individual Corning®
crymials and placed at -70°C overnight. Vials were then moved to liquid nitrogen storage
indefinitely.
The integrity of a cell line becomes drastically diminished after 20-25 passages as a
result of numerous selection events that gradually alter the genetic composition of the cells.
New cell lines were initiated from stocks in liquid nitrogen storage. A single vial was removed
from liquid nitrogen and thawed rapidly by heat from the palms of hands. Taking care to
pre\'ent contamination of the cells, the cryovial was wiped \\'ith 70% ethanol before opening.
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The contents oftbe vial were transferred to a 15 mL conical Falcon tube and 9 mL of fresh
6C2 culture media

was introduced in a drop-wise manner with occasional mixing of the

suspension. Cells were centrifuged at

250

x 9 for 5 minutes. The supernatant containing

culture media supplemented 10% DMSO was

remo~ed

and discafded. The pellet was

sl!lSpended in 10 mL offresb 6C2 culture media and transfened to a T-25 cuIrnre flask at 37
DC and 5% C02.

Synchronization ofCells. Nocodazole, a chemical synchronizing agent, arrests
cells in a prophase
to "pseudo-metaphase" stage ofmitosis 37 . The antimitotic agent inhibits
~

microtubule polymerization by binding to beta-tubulin and disrupting the formation of
interchain disulfide linkages38. Nocodazole also prevents the degradation of eyclin Bl; cells
caJlnot exit mitosis because the Cdkl-CyclinBl complex (MPF) remains intact and active 39,.
The low toxidtiy and reversible nature of nocodazole make the agent useful for obtaining
enriched mitotic populations of celli fOF studies of the cell cycle.

10 rnL of 6C2 ceUs at 85-90% confluence were transferred to a T-75 culture flask
containing 20 mL of gro\\1:b media supplemented with 30 f.lL of 0.4 mgjmL. nocodazole (final
concentration of 400 ngjuL nocodazole) and incubated at 37 DC and 5% C02 for 16 hours.
The cell suspension was transferred to a 50 mL conical Falcon rube and centrifuged at 250 x g
fOF 5 minutes. The supernatant containing the cellular synchronization agent was removed
and discarded and the pellet was washed with 5 mL of fresh 6C2 cuIhIre media and
centrifuged as above. Again, the supernatant was removed and discarded. Cells were
suspended in 30 mL,offresh 6C2 culture media, transferred in 5 mL aliq1llots to a six-well
plate, and incubated at 37°C and 5% CO2 for approximately 3-4 hours before treatment ,,,,;tb
DEB or ECH.
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Cell Cycle Analysis. Flow cytometric analysis was performed on live 6C2 chicken
erythro-progenitor cells to determine the relative distribut.ion of cells in the GO/GI, S, and
G2/M stages of the cell cycle under normal growth conditions. In flow cytometry, a given
population of cells is stained with one or more fluorescent, DNA-specific dyes. Stains used
exclush'ely for cell cycle analysis are membrane-permeant and non-fluorescent until bound
to DNA, allowing for the analysis oflive populations of cells ...without prior fixation. Upon
excitation of the dye, the level of fluorescence emitted by the labeled D~A of each individual
cell is proportional to the DNA mass of the cell. Cells in the GO/Gl stage contain one set of
paired chromosomes (2N), cells in S stage contain a variable amount of DNA between one
and two sets of paired chromosomes as a result of current DNA replication, and cells \\ithin
G~/M stages

contain two sets of paired chromosomes {4N)40. Hence, cells at the

G2/~1 stages

of the cell cycle emit twice the level of fluorescence as cells in GO/G, emit, and so on. Cell cycle
analysis of 6C2 chicken erythro-progenitor cells used Invitrogen Vybrant~ DyeCycle Greenn l
DNA stain, which is excited by the 488 nm '....avelength laser line of a flow cytometer and
emits fluorescence at approximately 520 nm 40 .
Cell cycle analysis was performed before each assay involving synchronized 6C2 cells
to verify successful enrichment of the population of cells arrested in G2/M by treatment with
nocodazole. 1 mL of the synchronized cell suspension was removed from the control well (6
mL total volume) of the six-well plate and transferred to a sterile flow cytometry rube. 1 mL of
a control cell suspension at a concentration of approximately 1 X 10 6 cells/mL was
transferred from aT-25 culture flask to another sterile flow cytometry tube. CellometerT:.l
automatic cell counting device determined the concentration of the cell suspension. Samples
were prepared for flow cytometry by the addition of 2 j.lL of Vybran~ DyeCycle Green DI stain
to each tube. Each sample was protected from light and incubated at 37°C for 30 minutes40 .
Flow cytometry data was collected with BD Biosciences CellQuest™ software.
FACSCalibur fluorescence detectors were set at 328 V (FLl), 605 V (FL2), and 350 V (FL3)
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while the scattering detector was assigned 210 V (SSC). The mode of the FLI detector was set
to linear rather than logarithmic; this pro\;ded better definition of population peaks during
analysis. A histogram of frequency versus fluorescence/emission was constructed from the
flow cytometry data of 10,000 cellular events. Regions were applied to data in order to
exclude dead cells and inert debris from analysis. Gates were drawn around the Go/G. and
G2/M cell populations and corresponding histogram statistics were calculated for the

percentages of total cells falling within each defined gate.

Treatment with DEB and ECH. Cytotoxicity studies were conducted for DEB
with unsynchronized cells, ECH \\1.th ullsynchronized cells, DEB with cells arrested in G2 /M,
and ECH with cells arrested in G2/M. Each experiment was performed in duplicate. For
control assays with unsynchronized cells, 1 mL of 80-85% confluent control 6C2 chicken
erythro-progenitor cells were transferred to each compartment of a six-well plate and 4 mL of
fresh 6C2 grO\\th media was added to each well (1:5 split, 5 mL final volume). Cells were
incubated at 37°C and 5% C02 for approximately 24 hours to allow for entry into the
logarithmic growth phase. As previously stated, cells arrested in mitosis were transferred in 5
mL aliquots to five of the six wells of a six well plate after treatment \\;th nocodazole. A 6 mL
aliquot was transferred to the control well; 1 mL was removed for cell cycle analysis before
the treatment assay. The procedure for synchronized cells differed from that for control cells;
making 1:5 dilutions of ceUs arrested in G2/M would result in 1) a period of lag phase growth
during which treatment is inappropriate, 2) low concentration of cells, and 3) necessary
release from mitosis in order to increase the cell concentration to that required for the flow
cytometry-based cytotoxicity study.
Stock dilutions (1.0 M and

10.0

M) ,,;th 6C2 culture media were made for both DEB

and ECH; each solution was made immediately preceding treatment ofthe cells to ensure
optimal potency of the compounds. Each cytotoxicity assay tested the viability of cells under
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°mM,

2.50 mM, 10

mM, 25 mM, 100 mM, and 250 mM cross-linker for 3'0, 60, 120, and 180

minute treatment periods. The varying amounts of alkylating agent were added to each ..'.-ell
to give the assigned final concentration; thorough mixing via gende pipetting helped to
diffuse the agent throughout each well. (Mixing was particularly important for ECH
cytotoxicity assays as ECH formed insoluble products in the aqueous cell suspension).
At the termination of each incubation period 1 mL of cellular suspension was

remo~ed

from each of the six wells and transferred to a 1.5 mL microcentrifuge tube. Samples were
centrifuged at

250

x 9 for 5 minutes, after which the supernatant was removed and discarded.

Visible pellets were suspended in 1 mL of IX PBS and centrifuged as above. The supernatant
was removed and discarded, and 1 mL of fresh 1X PBS added. Each suspension was
transferred to a labeled flow cytometry tube. 10 !J.L of 50 ngJmL propidium iodide stain in 1X
PBS was added to each tube. Tubes were covered with aluminum foil to protect the cellular
suspension from light and incubated at room temperature for approximately 10-15 minutes.

Flow Cytometryfor Cell Viability. Propidium iodide is a DNA-specific
fluorescent stain; however, unlike Vybrant® DyeCycle Green™ stain, propidium iodide
cannot penetrate the plasma membranes of living cells. During flow cytometric data
collection, PI emission indicates cell death: apoptotic and necrotic events facilitate
degradation of cellular membranes, drastically increasing permeability and allowing PI to
enter the dead cell and bind to nuclear DNA. Cells that do not emit fluorescence are
considered viable. Flow cytometry is a useful technique for assessing cell viability,
particularly since apoptotic cells cannot be quantified by the traditional trypan blue dye
exclusion test (data not shown).
Flow cytometry data was collected with BD Biosciences CellQuest1'M software.
FACSCalibur fluorescence detectors were set at 328 V (FL1), 605 V (FL2), and 525 V (FL3)
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while the scattering detector was assigned 210 V (SSe). The mode of the FL1 detector was set
to logarithmic.
Analytical dot plots were constructed for each sample of the cytotoxicity trial. A
quadrant was applied to the

°roM cross-linker, 30 minutes control sample; the lower right

quadrant was fitted to the population of viable cells. The control quadrant was transposed
onto all other samples to monitor shifts in the position of the population and uphold the
consistency of data. Quadrant statistics listed the total number of e"ents per quadrant.

Analysis ofData and Construction ofLDso Plots. Data \...ere collected from the
quadrant statistics table of each dot plot. Events occurring in the lower right quadrant (LR)
were considered viable, while events in the m·o upper quadrants (UL + DR) represented dead
cells. Events occurring in the lower left quadrant (LL) were deducted from the total number
of events; such data points were determined to be inert debris existing in the culture media.
The fraction of viable cells was calculated by dividing the number of events occurring in the
lower right quadrant (LR) by the adjusted total events (lO,ooo-LL).
Given that the discrete outcomes of cytotoxicity assays are binomial in nature (e.g.
"iable or not viable), linear and nonlinear regression models are inappropriate for analysis of
data. Instead, logistic regression or probit analysis are commonly used in cytotoxicity and
dose response experiments41 . The two functions are "almost indistinguishable", but logit
transformation has become increasingly popular in bioassay analysis because of its relatively
simple formula 42 . In the logistic regression function,

P(Z)

=

expZ
1+ expZ·

the proportion P is the probability of the binary outcome (viable or not viable) and Z is equal
to the function

Q

+~

X, where a

determines the location of the CUfye on x-axis,
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fi

is the slope, and X represents the continuous exposure variable 42 • For the purposes of the
cytotoxicity experiments, P was defined as the proportion of viable cells. Logit transformation
uses the inverse of the logistic regression function to convert proportional data limited to
values between 0 and 1 to an unlimited scalePA3 :

.

P

l091 t (P) = log 1 _ P = Z,

Logit transfonnation can makes use of loglo or the natural log, loge. Using Microsoft
Excel, proportions of viable cells were converted to logits with the natural log function.
Conveniently, the logit for P=O.50 is 0; logits for proportions greater than 0.50 are positive
while logits for proportions less than 0.50 are negative. Logits for proportions 0 and 1 are
infinite and cannot be calculated-no (This led to the exclusion of a few data points within the
180

minute incubation category, where the viable fraction had been severely diminished to

zero).
Two LDso plots were constructed for each of the four C)'totoricity experiments: logit
versus the concentration of cross-linking agent, and logit versus the 10glO of the concentration
of cross-linking agent. Linear trendlines for 30 minutes, 60 minutes, 120 minutes, and 180
minutes were fitted to the corresponding data points by the method ofleast squares. LDso
values ,,,"ere calculated for each incubation period from trendline equations. Equations were
chosen based on the R2 value that represents the goodness of fit for the trendline.
Additionally, smooth-line LDso scatter plots for average viable fraction versus concentration
of cross-linking agent were created in order to visualize the location of each incubation
period dose-response curve. These plots were helpful in assessing the accuracy of the
calculations.
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Results

Synchronization ofCells. Enrichment of the percentage of 6C2 erythro
progenitor cells in G2 /M by treatment with nocodazole was largely successful, both in terms
of actual synchronization and cell viability post-treatment. Preliminary experiments revealed
that nocodazole successfully arrested a large percentage of cells in G2 /M with little loss of
cellular integrity (Table 1). Attempts at arresting cells in GO/G1 with L-mimosine were mostly
unsuccessful due to the prevalence of cell death after chemical treatment (data not shown).
Additionally, nocodazole provided a means of synchronizing cells with low cell mortality and
the option of reversible arrest, though the latter was not utilized in the current study.
Synchronization of cells for use in the duplicate DEB cytotoxicity experiment \\ith
6C2 cells enriched in G2/M stages (Table 1) and the ECH cytotoxicity experiment (Table 2)
was relatively successful. Histograms comparing the distribution of cells in Go/G. and G2/M
of untreated cells with synchronized cells illustrate a pronounced shift from Go/G, to G2/M in
the second DEB assay (Figure 4). Histograms corresponding to ECH assays show slight
enrichments in G2/M but still maintain a strong GO/G 1 peak in comparison with the second
DEB assay (Figure 5).

Table 1. Histogram statistics for duplicate DEB cytotoxicity experiments with 6C2 eIj1hro-progenitor cells
enriched in G2 /M stages of the cell cycle. Table lists the percentage of cells in Go/G, stages and G2/M stages
in each histogram.
DEB G:JM Assay I
Treatment
Histogram G O/G 1 (%)
Control
A
58.3
Nocodazole
B
49.5

G:dM (0I0)

31.6
40.7
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DEB G2IM Assay II
Histogram G O/G 1 (%)
C
52.8
D
15.4

G 2 /M (010)

37.6

72.6
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Figure 4. Histograms illustrate the relative distnlmtion of cells throughout the stages of the cell cycle
for unsynchronized control cells and cells arrested in G'.l/M stages .....i th nocodazole: DEB cytotoxicity
experiments. Note the highly successful enrichment of cells in G2 /M stages by comparing histograms C
andD.
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Figure 5. Histograms illustrate the relative distribution of cells throughout the stages of the cell cycle
for unsynchronized control cells and cells arrested in G2 /M stages with nocodazole: ECH cytotoxicity
experiments. The two synchronizations were slightly less successful in comparison to arrest in G2/M
stages for the second DEB GdYl. cytotoxicity assay.
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The first population of 6C2 cells treated ".ith nocodazole for the synchronized DEB
assay appeared to be mostly successful; hov·;ever, analysis via gated statistics reveal that only
approximately 41% of cells within the treated population were arrested in G2/M (Table 1).
50% of cells remained in either Go or G,. Increasing the distance between Go/G" S, and G,dM

populations on the histogram may help with the accuracy of gate placement; the GO/G, gate
most likely contains a large portion of the S population. For the purposes of examining
cytotoxicity in relation the presence nuclear envelope, we can assume cells in Go, Gl and S to
be theoretically equivalent (nuclear envelope present).
Nocodazole-induced arrest of cells in G2 /M was highly successful for the population of
cells used in the second DEB G2 /M assay: 72.6% of cells were arrested in G"2./M while 15.4% of
cells remained in GO/G 1 (Table 1). Given that the concentration of the cell suspension was
roughly 1.0 x 10 6 cell/mL and each well contained 5 mL, we can calculate that approximately
5.0 X 10 6

cells were present in each well. Hence, 72.6% of cells translated to approximately

3.6 X 10 6 cells in G2 /M, and 15.4% of cells equates to about 7.7 x

105

cells in GO/G 1• Hence, in

the second DEB G2 /M assay approximately 2,860,000 more cells were arrested in G2 /M
stages than in GO/G 1 stages.

Table 2. Histogram statistics for duplicate ECH cytotoxicity experiments with 6C2 erythro-progenitor cells
enriched in G2/M stages of the cell cycle. Table lists the percentage of cells in GO/Gl stages and G,jM stages in
each histogram.
ECH G:JM Assay II

ECH G2./M Assay I

Treatment
Histogram
Control
E
F
Nocodazole

G O/G 1 (%)
60.6
30.2

G2 /M (0/0)

Histogram

GO /G 1 (%)

G2 /M (010)

24.7
54.2

G
H

57.0
30.0

37.8
58.8
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Though the synchronization of ceUs in the G:dM stages of the cell cycle was somewhat
less pronounced within the cell populations designated for treatment with ECH, overall
enrichment of cells in G2/M was successful in both assays. Data from histograms E and F
(Figure 5) indicated a 31% decrease in the Go/Gt population accompanied by a 30% increase
in the proportion of cells arrested in G2/M (Table 2). Reduction of the number of cells in
Go/G l was visually apparent between the control and nocodazole-treated histograms from the

first synchronized cell ECH assay (Figure 5). 6C2 cells synchronized for use in the second
assay displayed similar results. The number of cells in GO/GI decreased by approximately
27%. and the Gz/M cell population grew by 21% (Table 2). Again, results were accurately

represented by shifts in Go/G. and G,:dM peak heights for histograms G and H (Figure 5).
While complete synchronization of cells within the G2/M stages of the cell cycle is
desirable for analysis of cell-cycle dependent cytotoxicity, simple enrichment of cells in G2 /M
stages was useful to the study. The goal of synchronization was to produce a population of
cells in which there existed a shift toward Gz/M stages and nuclear envelope degradation.
Movement away from the control distribution and toward enrichment of G2/M stages serves
the purpose of creating a population of cells with a modified distribution of cells favoring the

G2/M stages of the cell cycle.

Cytotoxicity ofDEB and ECH in 6C2 erythro-progenitor cells. To assess the
relative cytotoxicity of DEB and ECH in vivo, viability was reported as a measure of the LD 50,
the concentration of agent at which 50% of cells are alive. Lower LDso concentrations indicate
increased cytotoxicity: smaller concentrations of the agent are required to obtain cytotoxic
effects. Data concerning the numbers of viable and dead cells were collected in duplicate for
control DEB-treated cells and control ECH-treated cells sepaFately via flow cytometry with
propidium iodide. The viable fractions of ceUs were calcUl!ated from the raw data for each
concentration of agent at the designated exposure time. The proportion of viable cells was
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transformed with logistic regression to fit a normal distribution curve. The logit, which is
equal to the natural log of the viable fraction divided by the proportion of dead cells, was
plotted against the concentration of agent or the log of the concentration of agent in
Microsoft Excel (Figures 6 and 7). These plots provided a linear relationship beh"'een the
viability (logit) and the concentration of DEB or ECH. Linear trendlines were fit to data from
each incubation period by the method oflea.st squares. Linear trendline equations in the Y=
fiX

+ b form and corresponding R2 values were recorded from both plots. Equations for use

in the calculation of LD50 concentrations were selected on the basis of "goodness of fit" as
indicated by R2 values; the equation with the R2 value closest to

1.0

was consistently used to

calculate LD so concentrations (Tables 3 and 4). Smooth-line scatter plots of the average
viable fraction versus the concentration of agent were also created in Excel to visualize the
shape of the sigmoidal dose-response curve for each of the cytotoxicity experiments (Figures
6 and 7).
DEB LD50 concentrations for 30 minute,

60

minute, 120 minute, and 180 minute

incubation periods were calculated to be 168 mM, 110 mM, 10.2 roM, and 4.54 mM,
respecti"ely (Table 5). ,A$ indicated, 30 minute and 60 minute LDso concentrations ,,'ere
derived from the logit v. [DEB] (mM) scatter plot whereas the LD so concentrations for the
120

minute and 180 minute data sets were calculate from the equations given by the logit vs.

log[DEB] scatter plot (Table 3). Variations in linear fit benveen the data sets may be
attributed to the shallow sigmoidal curve of 30 minute and 60 minute data in comparison to
the very steep dose response curve for 120 minute and 180 minute data (Figure 6).
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Table 5. LD so concentrations for DEB and ECH cytotoxicity experiments
with unsynchronized control6C2 erythro-progenitor cells.
Length of Treatment
30 min.
60 min.
120 min.
180 min.

COntrol Unsvnchronized 6C2 Cells
ECH LD so (mM)
94.9
74.5
6.24
2.14

DEB LD sQ (mM)
168
110
10.2
4.54

Cytotoxicity ofDEB and ECH in 6C2 erythro-progenitor cells enriched in
GRIM stages ofthe cell cycle. Cytotoxicity studies monitoring cell viability as a function
of the concentration of agent were perfonned for 6C2 eI)1:hro-progenitor cells enriched in
GdM stages of the cell cycle. The objective of the experiments was to determine the role of

the nuclear envelope in inhibition ofthe cytotoxic action of DEB and ECH. After successful
enrichment of cells in the G:I./M stages of the cell cycle by treatment with nocodazole, 6C2
cells were treated with varying concentrations of DEB and ECH (individually) for 30 minute,
60

minute, 120 minute, and 180 minute incubation periods. Post-treatment cell viability was

assessed \;a flow cytometry. Following the experimental procedures and analytical methods
used in the cytotoxicity experiments with unsynchronized control 6C2 cells allowed us to
compare the LD so cytotoxicity results for DEB and ECH betw'een unsynchronized and
sy11chronized cell populations. Additionally, inferences were made about the cytotoxicity of
DEB in comparison to ECH in terms of unsynchronized and G:I./M enriched cell experiments.
LD so concentrations for the 30 minute,

60

minute, 120 minute, and 180 minute

incubation periods of the DEB cytotoxicity experiment with 6C2 cells enriched in G2/M
stages were 68.9 mM, 81.9 mM, 19.6 mM, and 8.29 mM, respectively (Table 6). The smooth
line scatter plot for the average viable fraction versus the concentration of agent illustrated
that each of the four dose response curves were relatively similar in shape and slope (Figure
8). Slopes and R2 values were comparable between the 1:\\'0 logistic regression plots for all
treatments (Table 7).
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Discussion

Comparison of control DEB and ECH cytotoxicity studies indicates that ECH is
slightly more c}'totoxic to 6C2 erythro-progenitor cells than DEB at brief incubation periods,
but is comparable in cytotoxicity for longer exposure times (Table 5). Evaluation of DEB and
ECH cytotoxicity experiments with 6C2 cells arrested in G2jM stages re\'ealed that the
overall cytotoxicity of both bifunctional alkylators was greater in synchronized 6C2 cell
populations enriched in G2jM stages of the cell cycle (Table 6). Again, ECH is more cytotoxic
than DEB at incubation time<; less than 60 minutes but has similar cytotoxicity for treatment
times O\'er one hour. ECH may have displayed greater cytotoxicity due to its insolubility in
aqueous cell suspensions. Some of the ECH added to the 6C2 cell suspension precipitated out
of solution and most likely killed cells located on the bottom of the wells.
Results from the cytotoxicity experiments support the treatment of 6C2 cells v..ith 250
mM of DEB, ECH, and EBH in previously conducted QPCR studies. 6C2 cells were incubated
with varying concentrations (0.025 mM-2So mM) of bifunctional alkylating agent for
vaI);ng times (15 min.-I80 min.). QPCR analysis revealed that at a constant incubation time
of 1 hour there \\>'as little loss of PCR products (result of DNA damage) for concentrations less
than the 250 mM3s, Thus, subsequent cross-linking experiments used 250 mM of agent.
After submitting the manuscript titled, "Quantitative PCR analysis of diepoxybutane
and epihalohydrin damage to nuclear versus mitochondrial DNA3';" for publication, we
received referee reports that stated that DEB induces extreme toxicity at a concentration of
10 !lM. The reviewers requested that we provide dose-dependent survival cun'es in the
chicken 6C2 erythro-progenitor cells exposed to 2.5 mM to 250 mM of agent for various time
intervals, and explore the mechanism of cell death triggered by the agents.
These experiments show that at 30 minutes of treatment, nearly half of the 6C2 cell
population survived doses of 168 mM DEB and 95 mM ECH (Table 5). Our reviewers deemed
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such "mega-doses" as inappropriate; however, results indicate that 6C2 cells are ahle to
'withstand exposure to large doses of DEB or ECH for short periods of time. We chose brief
incubation periods to maintain the synchrony of arrested cells; incubation of 6C2 cells ".ith
1m..· doses of DEB or ECH for extended periods of time may disrupt synchrony and
population size. Furthermore, current work in the Millard Biochemistry Research Lab
demonstrates that incubation conditions of 20 IlM agent over 4 hours doesn't induce
significant cytopathologies, whereas 1 mM agent over 4 hours is sufficient for passage into
late apoptosis in our 6C2 cell line (Annexin Vjpropidium iodide stain)44. Future work will
investigate the concentrations of DEB and ECH required to induce apoptosis at 15 minute, 30
minute, and 1 hour incubation times.
Both DEB and ECH experiments indicated that these two bifunctional alkylators are
more cytotoxic during GzjM than during the other stages of the cell cycle, specifically the
Go/Gt interface and Glpopulation. These results may indicate the role of the nuclear envelope
(and other cellular membranes, such as the mitochondrial inner membrane) in excluding
smaIl, relatively polar molecules. Conversely, initial mortality by chemical synchronization
agents may have increased the cytotoxicity of DEB and ECH within the 30 minute and 60
minute treatment periods; this possibility necessitates exploration into the effect of the
starting viability on logistic regression models.
Interestingly, an increase in cytotoxicity during G'J./M stages was noted for 30 minute
and 60 minute incubation times, but little difference was observed in LD50 concentrations for
120

minute and 180 minute data sets. Examination of the smooth line scatter plots shows

that the dose response curves for 120 minutes and 180 minutes are relatively steep for both
control and synchronized cells. However, the shape of the 30 minute and 60 minute CUITes
was shallow ',ithin the control experiments and became increasingly sigmoidal with arrest in
G~jM

stages.
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This phenomenon may be due to logistic transfonnation of sigmoidal data to a linear
relationship. Low initial viability translates into a more negative logit and smaller Y
intercept. Given that the \riable fraction is limited to values of 0 to

1,

the high cytotoxicity (low

LD 50 value and lower viable fractions for smaller concentrations) of a compound ....;lllimit the
slope of the line. In comparing the slopes of the cytotoxicity of ECH control study (Table 4)
and the cytotoxicity of ECH synchronization experiment (Table 8) we find that the slopes of
the equations for data in the synchronization experiment are smaller, resulting in a shallow
trendline. Leveling oithe slope may actually increase the calculated viable fraction for a
specific concentration, making it seem that the cytotoxicity of the compound decreases \\rith
time.
While the initial results of these cytotoxicity studies are promising, other
considerations call for a larger sample size (triplicate or quadruplicate trials for each assay)
and the exploration of additional statistical methods of detennining an LD50 from a sigmoidal
dose response curve. Logistic regression requires that raw data undergo transformation to
abstract values in order to fit the data to a linear model. Transformation increases the
complexity of calculating standard deviations and standard errors of individual data points,
resulting in a statistical nightmare for all those who attempt it without working knowledge of
computer-based stats packages. Using a curve-fitting program would be beneficial in that it
allows for the calculation of standard deviations and the ability to more confidently define the
relationship between \oa.riables. One possibility is the least squares curve fitting solver tool in
Excel that fits sigmoidal curves to data on a logarithmic scale. The program use." a hyperbolic
equation: 1/(1 + (x/a)b), where x is the proportion of interest, and Q is solved as the LD so
concentration4S•
Additionally, thorough exploration of the effects of the cell cycle on the C)totoxicity of
DEB and ECH requires alternative methods for synchronization of cells in Go/G, and S in
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addition to G2 /M stages. Future goals include the complete comparison of DEB and ECH
CJ'totoxicity for each stage of the cell cycle.
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Conclusion

Our results suggest that ECH is more cytotoxic than DEB in both unsynchronized
control 6C2 erythro-progenitor cells and synchronized 6C2 erythro-progenitor cells enriched
in G..d M stages of the cell cycle. Treatment with either bifunctional alkylating agent induced
greater cytotoxicity in 6C2 cells enriched in G2 /M stages than in unsynchronized control 6C2
cells. Furthermore, data supports the use of 250 mM DEB and ECH in the previous QPCR
study as 6C2 cells can withstand "mega~doses" of each agent. Based on previous studies, we
believe that the cytotoxic effects of DEB and ECH result from DNA damage from the
formation of DNA adducts and covalent DNA interstrand cross-links6 ,12.13,l4.15,21. Greater
cytotoxicity of both agents in 6C2 cells enriched in G,dM stages of the cell cycle suggests that
the presence of the nuclear envelope-or any plasma membrane-may inhibit the reactivity of
DEB and ECH. Further work with a greater number of replicate assays and dose-response
curve fitting models is required to determine the statistical significance of our results.
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